RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Kaken Pharmaceutical Co Stock

Kaken Pharmaceutical Co ROA 2025

Kaken Pharmaceutical Co ROA

0.07

Ticker

4521.T

ISIN

JP3207000005

In 2025, Kaken Pharmaceutical Co's return on assets (ROA) was 0.07, a 123.91% increase from the 0.03 ROA in the previous year.

Kaken Pharmaceutical Co Aktienanalyse

What does Kaken Pharmaceutical Co do?

Kaken Pharmaceutical Co Ltd is a Japanese pharmaceutical company based in Tokyo. The company was founded in 1949 and has since grown continuously to establish itself as a flagship of the Japanese pharmaceutical industry. The company specializes in the production and sale of prescription and over-the-counter drugs. However, it has also heavily focused on research and development of new medications to expand its market share. Kaken Pharmaceutical's business model is to develop and manufacture high-quality products to ensure they meet the needs and requirements of customers. This includes a wide range of medications, ranging from pain relievers and antiallergics to cosmetic products. The company categorizes its products into five different categories: dermatology, pediatrics, oncology, gastroenterology, and orthopedics. Each of these categories specializes in treating and preventing various diseases, conditions, and complaints, offering a wide range of products. Dermatology is one of the key divisions of Kaken Pharmaceutical. The company offers medications for treating skin conditions such as psoriasis, eczema, dermatitis, and acne. One of its most well-known products is the anti-acne medication Isotretinoin. It works by reducing sebum production, thus reducing inflammation and pore blockage. Kaken Pharmaceutical's pediatrics products focus on treating children. Syrups and drops for symptom relief of colds, coughs, fevers, and diarrhea are among the products offered. In this category, Kaken Pharmaceutical also provides medications for treating children with ADHD. Oncology medications are offered by Kaken Pharmaceutical under the name "Kaken Pharma." These products are intended for the treatment of cancer diseases such as lung, breast, and stomach cancer. The company is constantly striving to improve its research and development to make cancer treatment more effective and efficient. The gastroenterology category focuses on treating digestive disorders such as heartburn, reflux, and gastric ulcers. Kaken Pharmaceutical has introduced several products, including drugs that inhibit stomach acid, which are offered in the form of tablets and granules. Orthopedic medications from Kaken Pharmaceutical are used to treat pain and inflammation of the skeletal system, such as relieving joint pain, arthritis, and osteoporosis. The most well-known product is the pain reliever Ibuprofen, which is available for both oral and topical use. In conclusion, Kaken Pharmaceutical Co Ltd is a company committed to meeting the medical and cosmetic needs of customers. Each product is carefully developed and manufactured to ensure the highest quality and effectiveness. With its wide range of products and research efforts, the company is an important player in the global pharmaceutical market. Kaken Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Kaken Pharmaceutical Co's Return on Assets (ROA)

Kaken Pharmaceutical Co's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Kaken Pharmaceutical Co's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Kaken Pharmaceutical Co's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Kaken Pharmaceutical Co’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Kaken Pharmaceutical Co stock

What is the Return on Assets (ROA) of Kaken Pharmaceutical Co this year?

The Return on Assets (ROA) of Kaken Pharmaceutical Co is 0.07 undefined this year.

What was the ROA of Kaken Pharmaceutical Co compared to the previous year?

The ROA of Kaken Pharmaceutical Co has increased by 123.91% compared to the previous year.

What consequences do high ROA have for investors of Kaken Pharmaceutical Co?

A high ROA is advantageous for investors of Kaken Pharmaceutical Co, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Kaken Pharmaceutical Co?

A low ROA can be unfavorable for investors of Kaken Pharmaceutical Co as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Kaken Pharmaceutical Co affect the company?

An increase in ROA of Kaken Pharmaceutical Co can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Kaken Pharmaceutical Co impact the company?

A reduction in the ROA of Kaken Pharmaceutical Co can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Kaken Pharmaceutical Co?

Some factors that can influence the ROA of Kaken Pharmaceutical Co include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Kaken Pharmaceutical Co important for investors?

The ROA of Kaken Pharmaceutical Co is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Kaken Pharmaceutical Co take to improve ROA?

To improve ROA, Kaken Pharmaceutical Co can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Kaken Pharmaceutical Co pay?

Over the past 12 months, Kaken Pharmaceutical Co paid a dividend of 75 JPY . This corresponds to a dividend yield of about 1.98 %. For the coming 12 months, Kaken Pharmaceutical Co is expected to pay a dividend of 77.7 JPY.

What is the dividend yield of Kaken Pharmaceutical Co?

The current dividend yield of Kaken Pharmaceutical Co is 1.98 %.

When does Kaken Pharmaceutical Co pay dividends?

Kaken Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of Kaken Pharmaceutical Co?

Kaken Pharmaceutical Co paid dividends every year for the past 22 years.

What is the dividend of Kaken Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 77.7 JPY are expected. This corresponds to a dividend yield of 2.05 %.

In which sector is Kaken Pharmaceutical Co located?

Kaken Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Kaken Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Kaken Pharmaceutical Co from 6/1/2025 amounting to 75 JPY, you needed to have the stock in your portfolio before the ex-date on 3/28/2025.

When did Kaken Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 6/1/2025.

What was the dividend of Kaken Pharmaceutical Co in the year 2024?

In the year 2024, Kaken Pharmaceutical Co distributed 150 JPY as dividends.

In which currency does Kaken Pharmaceutical Co pay out the dividend?

The dividends of Kaken Pharmaceutical Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Kaken Pharmaceutical Co

Our stock analysis for Kaken Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kaken Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.